The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide

Brain Research

Volumn 785, Issue 1, 1998, Pages 107-113

  Onoue, Hisashi ^a   Katusic, Zvonimir S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cerebral artery; Cyclic GMP; Guanylate cyclase; Nitric oxide; Potassium channel; Vasodilatation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CHARYBDOTOXIN; DIETHYLAMINODIAZEN 1 IUM 1,2 DIOATE; GUANYLATE CYCLASE INHIBITOR; NITRIC OXIDE; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; MIDDLE CEREBRAL ARTERY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; SMOOTH MUSCLE RELAXATION;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; BRADYKININ; CEREBRAL ARTERIES; CHARYBDOTOXIN; CYCLIC GMP; DOGS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FORSKOLIN; GUANYLATE CYCLASE; HYDRAZINES; ISOMETRIC CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROGEN OXIDES; OXADIAZOLES; QUINOXALINES; URIDINE TRIPHOSPHATE;

EID: 0032559655     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01393-0     Document Type: Article

References (36)

1. S.L. Archer, J.M.C. Huang, V. Hampl, D.P. Nelson, P.J. Shultz, E.K. Weir, Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 7583-7587.
2. V.M. Bolotina, S. Najibi, J.J. Palacino, P.J. Pagano, R.A. Cohen, Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle, Nature 368 (1994) 850-853.
3. D.S. Bredt, S.H. Snyder, Nitric oxide: a physiologic messenger molecule, Annu. Rev. Biochem. 63 (1994) 175-195.
4. R.L. Dundore, D.M. Clas, L.T. Wheeler, P.G. Habeeb, D.C. Bode, R.A. Buchholz, P.J. Silver, E.D. Pagani, Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats, Eur. J. Pharmacol. 249 (1993) 293-297.
5. F.M. Faraci, J.E. Brian, Nitric oxide and the cerebral circulation, Stroke 25 (1994) 692-703.
6. R.F. Furchgott, J.V. Zawadzki, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature 288 (1980) 373-376.
7. J. Garthwaite, E. Southam, C.L. Boulton, E.B. Nielsen, K. Schmidt, B. Mayer, Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, Mol. Pharmacol. 48 (1995) 184-188.
8. A.S. Gidari, R.F. Furchgott, D. Jothianandan, Inhibition by LY83583 of endothelium-dependent relaxation of rabbit aorta, FASEB J. 3 (1989) A1178.
9. G. Gimenez-Gallego, M.A. Navia, J.P. Reuben, G.M. Katz, G.J. Kaczorowski, M.L. Garcia, Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 3329-3333.
10. A.L. Harris, B.M. Lemp, R.G. Bentley, M.H. Perrone, L.T. Hamel, P.J. Silver, Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle, J. Pharmacol. Exp. Ther. 249 (1989) 394-400.
11. C. Iadecola, Bright and dark sides of nitric oxide in ischemic brain injury, Trends Neurosci. 20 (1997) 132-139.
12. L.J. Ignarro, P.J. Kadowitz, The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation, Annu. Rev. Pharmacol. Toxicol. 25 (1985) 171-191.
13. Z.S. Katusic, J.T. Shepherd, P.M. Vanhoutte, Vasopressin causes endothelium-dependent relaxations of the canine basilar artery, Circ. Res. 55 (1984) 575-579.
14. 1-vasopressinergic receptors, J. Pharmacol. Exp. Ther. 236 (1986) 166-170.
15. Z.S. Katusic, J.T. Shepherd, P.M. Vanhoutte, Endothelium-dependent contraction to stretch in canine basilar arteries, Am. J. Physiol. 252 (1987) H671-H673.
16. U. Koedel, A. Bernatowicz, R. Paul, K. Frei, A. Fontana, H.W. Pfister, Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide, Ann. Neurol. 37 (1995) 313-323.
17. T. Malinski, F. Bailey, Z.G. Zhang, M. Chopp, Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion, J. Cereb. Blood Flow Metab. 13 (1993) 355-358.
18. C.M. Maragos, D. Morley, D.A. Wink, T.M. Dunams, J.E. Saavedra, A. Hoffman, A.A. Bove, L. Isaac, J.A. Hrabie, L.K. Keefer, Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide: vasorelaxant effects, J. Med. Chem. 34 (1991) 3242-3247.
19. J.J. Marshall, E.P. Wei, H.A. Kontos, Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide, Am. J. Physiol. 255 (1988) H847-H854.
20. + channels from mammalian skeletal muscle, Nature 313 (1985) 316-318.
21. E. Morikawa, M.A. Moskowitz, Z. Huang, T. Yoshida, K. Irikura, T. Dalkara, L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat, Stroke 25 (1994) 429-435.
22. D. Morley, C.M. Maragos, X.-Y. Zhang, M. Boignon, D.A. Wink, L.K. Keefer, Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators, J. Cardiovasc. Pharmacol. 21 (1993) 670-676.
23. M.A. Moro, R.J. Russell, S. Cellek, I. Lizasoain, Y. Su, V.M. Darley-Usmar, M.W. Radomski, S. Moncada, cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 1480-1485.
24. M.J. Muller, H.P. Baer, Relaxant effects of forskolin in smooth muscle: role of cyclic AMP, Naunyn-Schmiedeberg's Arch. Pharmacol. 322 (1983) 78-82.
25. M.T. Nelson, J.M. Quayle, Physiological roles and properties of potassium channels in arterial muscle, Am. J. Physiol. 268 (1995) C799-C822.
26. H. Onoue, Z.S. Katusic, Role of potassium channels in relaxations of canine middle cerebral arteries induced by nitric oxide donors, Stroke 28 (1997) 1264-1271.
27. R.M.J. Palmer, A.G. Ferrige, S. Moncada, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature 327 (1987) 524-526.
28. B.E. Robertson, R. Schubert, J. Hescheler, M.T. Nelson, cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells, Am. J. Physiol. 265 (1993) C299-C303.
29. K.B. Seamon, J.M. Daly, Forskolin: a unique diterpene activator of cyclic AMP- generating systems, J. Cyclic Nucleotide Res. 7 (1981) 201-224.
30. C.G. Sobey, F.M. Faraci, Effect of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles, Stroke 28 (1997) 837-843.
31. J.S. Stamler, Redox signaling: nitrosylation and related target interactions of nitric oxide, Cell 78 (1994) 931-936.
32. Y. Takase, T. Saeki, M. Fujimoto, I. Saito, Cyclic GMP phosphodiesterase inhibitors: 1. The discovery of a novel potent inhibitor, 4-((3,4-(methylenedioxy)benzyl)amino)-6,7,8-trimethoxyquinazoline, J. Med. Chem. 36 (1993) 3765-3770.
33. M. Ueno, T.J. Lee, Endotoxin decreases the contractile responses of the porcine basilar artery to vasoactive substances, J. Cereb. Blood Flow Metab. 13 (1993) 712-719.
34. + channels in vascular smooth muscle cells, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9360-9364.
35. M.S. Wolin, P.D. Cherry, J.M. Rodenburg, E.J. Messina, G. Kaley, Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion, J. Pharmacol. Exp. Ther. 254 (1990) 872-876.
36. F. Zhang, J.G. White, C. Iadecola, Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia, J. Cereb. Blood Flow Metab. 14 (1994) 217-226.